Countries average performance (HIV, TB, and Malaria) since 2010
The Global Fund achievement in fighting HIV, TB and Malaria
HIV, TB and Malaria prevalence in 2013
The Global fund and the MENA region

GFO Articles

Georgia has developed a transition plan in response to gradual reductions over the years to its allocations from the Global Fund. The goal of the Georgia Transition Plan is to ensure a smooth transitioning to full domestic funding of the HIV and TB programs by 2022 without compromising services...

8 Aug 2017

The Global Fund has unveiled its plans for the $260 million earmarked for multi-country approaches in the 2017-2019 allocations. The multi-country funding is part of a larger pot of money ($800 million) set aside for catalytic investments. In addition to the multi-country approaches, the...

8 Aug 2017

Several important HIV-related announcements were made in the last few weeks. We provide short summaries.

“The scales have tipped”

UNAIDS announced on 20 July 2017 that in 2016, for the first time, more than half of the people living with HIV (19.5 million of the 36.7 million living...

8 Aug 2017

The Secretariat has made progress in improving consultant management processes, particularly over the last year and half. Consultant costs, as a percentage of total staff costs, have gone down from 35% in 2015 to 19% in 2016. Processes and compliance have improved. The Secretariat is aware of...

8 Aug 2017


A thematic review of fraud reporting by four international NGOs (INGOs), conducted by the Office of the Inspector General (OIG), has concluded that all four had strong anti-fraud policies and procedures in place. The OIG said that there were only a few examples of under-reporting, which have...

8 Aug 2017

Aidspan is a non-profit organization based in Kenya whose mission is to reinforce the effectiveness of the Global Fund to Fight AIDS, Tuberculosis and Malaria by serving as an independent watchdog of the Fund and its grant implementers

Accountability for Global Fund Grants in Malawi
29 Jun 2017

The Global Fund is the single most important source of funding for HIV/AIDS, TB and malaria in Malawi, where it
has invested approximately US$936 million since 2003. Malawi’s HIV/AIDS prevalence (9.1%) among adults aged
15-49 years ranks among the highest in the world and the country is also among the high burden HIV/AIDS/TB